drugset / Trial / NCT00347490

HENOX: Enoxaparine in Hemodialysis

NCT00347490

Phase 4 Completed 100 enrolled Sanofi
Non-randomizedSingle-groupOpen-labelTreatment

Summary

Primary objective: To assess clinical efficacy of single bolus anticoagulation with Enoxaparin in chronic hemodialysis Secondary objective: To assess safety and tolerability by the number of spontaneously reported adverse events by patients

Timeline

Start
2006-05
Primary completion
2007-04
Completion
2007-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Enoxaparin sodium Other / unclassified

Indications

No indication recorded.